BCRX
BIOCRYST PHARMACEUTICALS INC
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Revenue
$25.2M
↓ 4.4%
Operating Income
$341.0M
↑ 13508.9%
Total Assets
$514.2M
↑ 4.8%
EPS (Diluted)
$1.21
↑ 381.4%
Net Income
$263.9M
↑ 396.9%
Total Liabilities
$633.3M
↓ 34.5%
Shareholders' Equity
$-119153000.00
↑ 75.0%
Long-term Debt
$0.00
↓ 100.0%

Recent SEC Filings

Form Type Filed Date Link
4 9/2/2026 View on SEC
4 9/2/2026 View on SEC
4 9/2/2026 View on SEC
4 9/2/2026 View on SEC
4 9/2/2026 View on SEC
SCHEDULE 13G/A 8/14/2026 View on SEC
SCHEDULE 13G 8/7/2026 View on SEC
S-8 8/5/2026 View on SEC
10-Q 8/5/2026 View on SEC
8-K 8/5/2026 View on SEC

Company Information

Field Value
Ticker BCRX
Company Name BIOCRYST PHARMACEUTICALS INC
CIK 882796
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 919-859-1302